H.-F. Chow, G.-X. Wang / Tetrahedron 63 (2007) 7407–7418
7415
41.0, 24.7, 22.8, 22.1, 21.3; MS (FAB): m/z 369 [(M+H)+,
94%]; HRMS (L-SIMS): calcd for C22H29N2O3 (M+H)+:
369.2173, found 369.2178; Anal. Calcd for C22H28N2O3:
C, 71.71, H, 7.66, N, 7.60. Found: C, 71.56, H, 7.72, N, 7.61.
55.6, 21.3; MS (FAB): m/z 343 [(M+H)+, 54%]; HRMS
(L-SIMS): calcd for C19H23N2O4 (M+H)+: 343.1652, found
343.1655; Anal. Calcd for C19H22N2O4: C, 66.65, H, 6.48,
N, 8.18. Found: C, 66.34, H, 6.47, N, 8.03.
4.2.5. 5-Phe (P¼Boc). Starting from Boc-phenylalanine
(26.5 g, 100 mmol), 3,5-dimethylaniline (13.3 g, 110 mmol),
and EEDQ (27.2 g, 110 mmol), the title compound (31.3 g,
85%) was obtained as a white solid by precipitation from
acetone/Et2O. Mp: 143–144 ꢁC. [a]D ꢂ15.4 (c 1.0,
4.2.9. 5-Asn (P¼Cbz). Starting from Cbz-asparagine (5.30 g,
19.9 mmol), 3,5-dimethylaniline (2.65 g, 21.9 mmol), and
EEDQ (5.41 g, 21.9 mmol), the target product (5.00 g,
68%) was obtained as a white solid by precipitation from
acetone/Et2O. Mp: 156–158 ꢁC; [a]D ꢂ2.3 (c 0.90, DMF);
1H NMR: d 9.89 (1H, s), 7.58 (1H, d, J¼7.8), 7.41–7.30
(6H, m), 7.27 (2H, s), 6.99 (1H, s), 6.73 (1H, s), 5.07 (2H,
s), 4.51 (1H, q, J¼7.8), 2.59–2.45 (2H, m), 2.26 (6H, s);
13C NMR: d 171.0, 169.9, 155.7, 138.7, 137.5, 136.8,
128.3, 127.7, 124.7, 117.0, 65.4, 52.3, 37.1, 21.0; MS
(FAB): m/z 370 [(M+H)+, 68%]; HRMS (L-SIMS): calcd
for C20H23N3O4 (M+H)+: 370.1761, found 370.1756;
Anal. Calcd for C20H23N3O4: C, 65.03, H, 6.28, N, 11.37.
Found: C, 65.01, H, 6.27, N, 11.35.
1
CHCl3); H NMR (CDCl3): d 7.67 (1H, br s), 7.35–7.23
(5H, m), 7.00 (2H, s), 6.73 (1H, s), 5.16 (1H, br s), 4.46–
4.35 (1H, m), 3.13 (2H, d, J¼6.9), 2.26 (6H, s), 1.42 (9H,
s); 13C NMR (CDCl3): d 169.4, 155.7, 138.6, 137.1, 136.7,
129.3, 128.8, 127.0, 126.2, 117.8, 80.5, 56.7, 38.5,
28.3, 21.3; MS (FAB): m/z 369 [(M+H)+, 30%]; HRMS
(L-SIMS): calcd for C22H29N2O3 (M+H)+: 369.2173, found
369.2179; Anal. Calcd for C22H28N2O3: C, 71.71, H, 7.66,
N, 7.60. Found: C, 71.69, H, 7.71, N, 7.51.
4.2.6. 5-Asp b-benzyl ester (P¼Boc). Starting from
Boc-aspartic acid b-benzyl ester (16.2 g, 50.1 mmol), 3,5-
dimethylaniline (6.68 g, 55.1 mmol), and EEDQ (13.6 g,
55.1 mmol), the target compound (16.1 g, 75%) was ob-
tained as a white solid by precipitation from acetone/Et2O.
4.2.10. 5-Pro (P¼Cbz). Starting from Cbz-proline (5.00 g,
20.1 mmol), 3,5-dimethylaniline (2.67 g, 22.1 mmol), and
EEDQ (5.46 g, 22.1 mmol), the target compound (4.60 g,
65%) was obtained as a white solid by precipitation from
acetone/Et2O. Mp: 124–126 ꢁC; [a]D ꢂ129.1 (c 0.65,
1
1
Mp: 133–135 ꢁC; [a]D ꢂ25.8 (c 0.55, CHCl3); H NMR
CHCl3); H NMR: d 9.92 and 9.90 (total 1H, s), 7.45–7.35
(CDCl3): d 8.42 (1H, br s), 7.32–7.28 (5H, m), 7.12 (2H,
s), 6.75 (1H, s), 5.82 (1H, br s), 5.16 (1H, d, J¼12.3), 5.13
(1H, d, J¼12.3), 4.70–4.59 (1H, m), 3.06 (1H, dd, J¼17.1
and 4.2), 2.79 (1H, dd, J¼17.1 and 6.3), 2.28 (6H, s), 1.47
(9H, s); 13C NMR (CDCl3): d 171.8, 168.7, 155.8, 138.6,
137.3, 135.2, 128.6, 128.4, 128.2, 126.2, 117.6, 80.8, 66.9,
51.3, 35.8, 28.2, 21.3; MS (FAB): m/z 427 [(M+H)+,
57%); HRMS (L-SIMS): calcd for C24H31N2O5 (M+H)+:
427.2227, found 427.2230; Anal. Calcd for C24H30N2O5:
C, 67.59, H, 7.09, N, 6.57. Found: C, 67.59, H, 7.15, N, 6.52.
(2H, m), 7.35–7.14 (5H, m), 6.74 (1H, s), 5.15–4.95 (2H,
m), 4.42–4.32 (1H, m), 3.60–3.40 (2H, m), 2.27 (6H, s),
2.27–2.23 (1H, m), 2.00–1.82 (3H, m); 13C NMR: d 170.8,
170.5, 153.9, 153.6, 138.7, 138.6, 137.4, 136.9, 136.7,
128.3, 127.9, 127.7, 127.4, 126.8, 124.7, 124.6, 117.1,
116.9, 65.8, 65.7, 60.4, 59.8, 47.1, 46.5, 31.2, 30.1, 23.8,
23.0, 21.0; MS (FAB): m/z 353 [(M+H)+, 93%]; HRMS
(L-SIMS): calcd for C21H25N2O3 (M+H)+: 353.1860, found
353.1861; Anal. Calcd for C21H24N2O3: C, 71.75, H, 6.86,
N, 7.95. Found: C, 71.36, H, 6.83, N, 7.93.
4.2.7. 5-Tyr (P¼Cbz). Starting from Cbz-tyrosine (6.30 g,
20.0 mmol), 3,5-dimethylaniline (2.66 g, 22.0 mmol), and
EEDQ (5.43 g, 22.0 mmol), the target compound (6.70 g,
80%) was obtained as a white solid by precipitation from ace-
tone/Et2O. Mp: 153–155 ꢁC; [a]D +38.3 (c 0.65, DMF); 1H
NMR: d 9.94 (1H, s), 9.24 (1H, s), 7.63 (1H, d, J¼8.1),
7.41–7.20 (7H, m), 7.15 (2H, d, J¼8.1), 6.75–6.60 (3H, m),
5.01 (2H, s), 4.38–4.28 (1H, m), 2.93 (1H, dd, J¼13.5 and
4.5), 2.75 (1H, dd, J¼13.5 and 10.2), 2.27 (6H, s); 13C
NMR: d 170.5, 155.8, 155.7, 138.6, 137.5, 136.9, 130.1,
128.2, 127.8, 127.6, 127.4, 124.8, 117.0, 114.8, 65.2, 57.2,
36.7, 21.0; MS (FAB): m/z 419 [(M+H)+, 24%]; HRMS
(L-SIMS): calcd for C25H26N2O4 (M+H)+: 419.1965, found
419.1974; Anal. Calcd for C25H26N2O4: C, 71.75, H, 6.26,
N, 6.69. Found: C, 71.67, H, 6.29, N, 6.53.
4.3. (S)-N-Butyl-2-benzyloxycarbonylamino-3-phenyl-
propamide
A solution of Cbz-phenylalanine (6.00 g, 20.0 mmol),
n-butylamine (1.61 g, 22.0 mmol), and EEDQ (5.45 g,
22.0 mmol) was stirred in THF at 20 ꢁC for 24 h. The solvent
was removed under reduced pressure and the residue was
chromatographed on silica gel (eluent: hexane/EtOAc¼1/1)
to give the target product (5.70 g, 80%) as a white solid. Rf:
0.66 (hexane/EtOAc¼1/1); Mp: 127–130 ꢁC; [a]D +12.3 (c
1
0.50, CHCl3); H NMR (CDCl3): d 7.29–7.05 (10H, m),
5.73 (1H, br s), 5.50–5.40 (1H, m), 4.98 (2H, s), 4.29 (1H,
q, J¼7.2), 3.15–2.90 (4H, m), 1.30–1.17 (2H, m), 1.17–
1.03 (2H, m), 0.77 (3H, d, J¼7.2); 13C NMR (CDCl3):
d 170.6, 155.9, 136.6, 136.1, 129.2, 128.6, 128.5, 128.1,
127.9, 126.9, 66.9, 56.4, 39.1, 38.9, 31.2, 19.8, 13.6; MS
(FAB): m/z 355 [(M+H)+, 28%]; HRMS (L-SIMS): calcd
for C21H27N2O3 (M+H)+: 355.2016, found 355.2019;
Anal. Calcd for C21H26N2O3: C, 71.16, H, 7.39, N, 7.90.
Found: C, 71.06, H, 7.51, N, 7.76.
4.2.8. 5-Ser (P¼Cbz). Starting from Cbz-serine (4.80 g,
20.1 mmol), 3,5-dimethylaniline (2.67 g, 22.1 mmol), and
EEDQ (5.46 g, 22.1 mmol), the title compound (4.80 g,
70%) was obtained as a white solid by precipitation from ace-
tone/Et2O. Mp: 150–152 ꢁC; [a]D ꢂ10.7 (c 0.65, DMF); 1H
NMR (CDCl3): d 8.48 (1H, br s), 7.38–7.32 (5H, m), 7.10
(2H, s), 6.77 (1H, s), 5.95–5.88 (1H, m), 5.17 (2H, s),
4.34–4.20 (2H, m), 3.78–3.65 (1H, m), 3.00–2.90 (1H, m),
2.29 (6H, s); 13C NMR (CDCl3): d 169.1, 157.2, 138.8,
137.0, 135.8, 128.6, 128.4, 128.1, 126.5, 117.9, 67.6, 62.5,
4.4. (S)-N-(3,5-Dimethylphenyl)-2-hydroxy-3-phenyl-
propamide
A mixture of (S)-2-hydroxy-3-phenylpropionic acid11 (3.30 g,
19.9 mmol), 3,5-dimethylaniline (2.65 g, 21.8 mmol), and